Molecular Formula | C20H21F3N8O3S
|
Molar Mass | 510.49 |
Density | 1.495±0.06 g/cm3(Predicted) |
Solubility | DMSO: ≥ 39 mg/mL |
Appearance | solid |
Color | White |
pKa | 15.16±0.46(Predicted) |
Storage Condition | -20°C (des.) |
Stability | Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
In vitro study | VS-6063 significantly inhibited pFAK (Tyr397) expression in both paclitaxel-sensitive (SKOV3ip1) and paclitaxel-resistant (SKOV3-TR) cell lines. The combination of VS-6063 and paclitaxel synergistically reduced proliferation and increased apoptosis of SKOV3ip1,SKOV3-TR,HeyA8 and HeyA8-MDR cells. Combination of VS-6063 and Y15 synergistically reduced the viability, colony formation, and cell adhesion of thyroid cancer cell lines. |
In vivo study | In PTX-sensitive and PTX-Resistant Models, VS-6063 (50 mg/kg p.o.) in combination with paclitaxel enhanced growth inhibition. |